Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark

Motivated by the need to assess HIV vaccine efficacy, previous studies proposed an extension of the discrete competing risks proportional hazards model, in which the cause of failure is replaced by a continuous mark only observed at the failure time. However the model assumptions may fail in several ways, and no diagnostic testing procedure for this situation has been proposed. A goodness-of-fit test procedure for the stratified mark-specific proportional hazards model in which the regression parameters depend nonparametrically on the mark and the baseline hazards depends nonparametrically on both time and the mark is proposed. The test statistics are constructed based on the weighted cumulative mark-specific martingale residuals. The critical values of the proposed test statistics are approximated using the Gaussian multiplier method. The performance of the proposed tests are examined extensively in simulations for a variety of the models under the null hypothesis and under different types of alternative models. An analysis of the 'Step' HIV vaccine efficacy trial using the proposed method is presented. The analysis suggests that the HIV vaccine candidate may increase susceptibility to HIV acquisition.

[1]  Thomas A. Louis,et al.  Nonparametric estimation of the joint distribution of survival time and mark variables , 1998 .

[2]  Peter B. Gilbert,et al.  Inferences on relative failure rates in stratified mark‐specific proportional hazards models with missing marks, with application to human immunodeficiency virus vaccine efficacy trials , 2015 .

[3]  Mei Li,et al.  Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials. , 2013, Biostatistics.

[4]  John D. Kalbfleisch,et al.  Misspecified proportional hazard models , 1986 .

[5]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[6]  Subhash R. Lele,et al.  Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials , 1999 .

[7]  Erhard Cramer,et al.  Progressively Type-II censored competing risks data from Lomax distributions , 2011, Comput. Stat. Data Anal..

[8]  L. J. Wei,et al.  The Robust Inference for the Cox Proportional Hazards Model , 1989 .

[9]  Haoxuan Zhou,et al.  Failure time regression with continuous covariates measured with error , 2000 .

[10]  David Heckerman,et al.  Leveraging Information Across HLA Alleles/Supertypes Improves Epitope Prediction , 2007, J. Comput. Biol..

[11]  Donghoon Han,et al.  Inference for a simple step-stress model with competing risks for failure from the exponential distribution under time constraint , 2010, Comput. Stat. Data Anal..

[12]  Ren Johansen An Empirical Transition Matrix for Non-homogeneous Markov Chains Based on Censored Observations , 1978 .

[13]  R. Hashemi,et al.  Analysis of dependent competing risks in the presence of progressive hybrid censoring using Marshall-Olkin bivariate Weibull distribution , 2015, Comput. Stat. Data Anal..

[14]  Ian W McKeague,et al.  PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS. , 2009, Annals of statistics.

[15]  S W Lagakos,et al.  Properties of proportional-hazards score tests under misspecified regression models. , 1984, Biometrics.

[16]  M Schumacher,et al.  Statistical analysis of quality of life data in cancer clinical trials. , 1990, Statistics in medicine.

[17]  Peter B Gilbert,et al.  Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks. , 2012, Scandinavian journal of statistics, theory and applications.

[18]  Peter B. Gilbert,et al.  Tests for Comparing Mark-Specific Hazards and Cumulative Incidence Functions , 2004, Lifetime data analysis.

[19]  S Brunak,et al.  Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. , 2003, Tissue antigens.

[20]  Hulin Wu,et al.  Semiparametric Time‐Varying Coefficients Regression Model for Longitudinal Data , 2005 .

[21]  Devan V Mehrotra,et al.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.

[22]  Ian W McKeague,et al.  The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy. , 2007, Biostatistics.

[23]  S W Lagakos,et al.  Effects of mismodelling and mismeasuring explanatory variables on tests of their association with a response variable. , 1988, Statistics in medicine.

[24]  Z. Ying,et al.  Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .